Retained Earnings (Accumulated Deficit) in USD of Alzamend Neuro, Inc. from Q1 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Alzamend Neuro, Inc. quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q1 2020 to Q2 2025.
  • Alzamend Neuro, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending July 31, 2025 was -$61.2M, a 11.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 -$61.2M -$6.24M -11.4% Jul 31, 2025 10-Q 2025-09-10
Q1 2025 -$58.5M -$4.51M -8.36% Apr 30, 2025 10-Q 2025-09-10
Q4 2024 -$57.4M -$4.23M -7.95% Jan 31, 2025 10-Q 2025-03-10
Q3 2024 -$56.4M -$5.9M -11.7% Oct 31, 2024 10-Q 2024-12-11
Q2 2024 -$55M -$7.39M -15.5% Jul 31, 2024 10-Q 2024-09-11
Q1 2024 -$54M -$9.95M -22.6% Apr 30, 2024 10-K 2025-07-22
Q4 2023 -$53.2M -$12.4M -30.4% Jan 31, 2024 10-Q 2024-03-25
Q3 2023 -$50.5M -$15.2M -42.9% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 -$47.6M -$15.4M -47.7% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 -$44.1M -$14.9M -51% Apr 30, 2023 10-K 2024-07-30
Q4 2022 -$40.8M -$15.4M -61% Jan 31, 2023 10-Q 2023-03-15
Q3 2022 -$35.3M -$12.6M -55.3% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 -$32.2M -$13.1M -68.3% Jul 31, 2022 10-Q 2022-09-13
Q1 2022 -$29.2M -$12.4M -73.4% Apr 30, 2022 10-K 2023-07-27
Q4 2021 -$25.3M Jan 31, 2022 10-Q 2022-03-15
Q3 2021 -$22.8M Oct 31, 2021 10-Q 2021-12-13
Q2 2021 -$19.2M Jul 1, 2021 10-Q 2021-09-13
Q1 2021 -$16.8M -$5.05M -42.8% Apr 30, 2021 10-K 2022-07-19
Q1 2020 -$11.8M Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.